GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis

摘要： <正>Hepatic fibrosis is a consequence of chronic liver disease, which can lead to cirrhosis and liver failure. There is no Food and Drugs Administration approved therapy for liver fibrosis to... ... （共2頁）